Renal Cancer - Results from #3780

Post-operative complications increase the risk of long-term chronic kidney disease after nephron sparing surgery in renal cancer patients with normal preoperative renal function. February 18, 2019

Long-term survival and prognostic factors for locally advanced renal cell carcinoma with renal vein tumor thrombus. February 18, 2019

Emerging Molecular Technologies in Renal Cell Carcinoma: Liquid Biopsy. February 18, 2019

Tracking Cancer Evolution Reveals Constrained Routes to Metastases: TRACERx Renal. February 17, 2019

Deterministic Evolutionary Trajectories Influence Primary Tumor Growth: TRACERx Renal. February 17, 2019

Prostate cancer and subsequent nutritional outcomes: the role of diagnosis and treatment. February 15, 2019

Primitive neuroectodermal tumour with synchronous ipsilateral clear cell carcinoma of the kidney. February 15, 2019

Cullin 5 is a novel candidate tumor suppressor in renal cell carcinoma involved in the maintenance of genome stability. February 15, 2019

Preoperative controlling nutritional status (CONUT) score as a novel immune-nutritional predictor of survival in non-metastatic clear cell renal cell carcinoma of ≤ 7 cm on preoperative imaging. February 15, 2019

FDA Accepts sBLA and Grants Priority Review for BAVENCIO® (avelumab) Plus INLYTA® (axitinib) for the Treatment of Advanced Renal Cell Carcinoma February 15, 2019

Interactive virtual 3D models of renal cancer patient anatomies alter partial nephrectomy surgical planning decisions and increase surgeon confidence compared to volume-rendered images. February 14, 2019

CXCL13/CXCR5 Axis Predicts Poor Prognosis and Promotes Progression Through PI3K/AKT/mTOR Pathway in Clear Cell Renal Cell Carcinoma. February 14, 2019

Diagnostic Imaging for Solid Renal Tumors: A Pictorial Review. February 14, 2019

Stereotactic radiotherapy as a treatment option for renal tumours in the solitary kidney: a multicenter analysis from the International Radiosurgery Oncology Consortium for Kidney (IROCK). February 13, 2019

What Survival Benefits are Needed to Make Adjuvant Sorafenib Worthwhile After Resection of Intermediate- or High-Risk Renal Cell Carcinoma? Clinical Investigators' Preferences in the SORCE Trial. February 13, 2019

A new prognostic model for survival in second line for metastatic renal cell carcinoma: development and external validation. February 13, 2019

Radiological Response Heterogeneity Is of Prognostic Significance in Metastatic Renal Cell Carcinoma Treated with Vascular Endothelial Growth Factor-targeted Therapy. February 12, 2019

Partial nephrectomy versus radical nephrectomy for large (≥ 7 cm) renal tumors: A systematic review and meta-analysis. February 12, 2019

Perioperative, oncological and functional outcomes after robotic partial nephrectomy vs. cryoablation in the elderly: A propensity score matched analysis. February 12, 2019

FDA Accepts sBLA and Grants Priority Review for BAVENCIO® (avelumab) Plus INLYTA® (axitinib) for the Treatment of Advanced Renal Cell Carcinoma February 12, 2019

Page 190 of 456